FR1731M - New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions. - Google Patents

New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.

Info

Publication number
FR1731M
FR1731M FR885433A FR885433A FR1731M FR 1731 M FR1731 M FR 1731M FR 885433 A FR885433 A FR 885433A FR 885433 A FR885433 A FR 885433A FR 1731 M FR1731 M FR 1731M
Authority
FR
France
Prior art keywords
pyrazole
therapy
drug
treatment
inflammatory conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR885433A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR1731M publication Critical patent/FR1731M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR885433A 1961-01-24 1962-01-22 New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions. Active FR1731M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH77061A CH401071A (en) 1961-01-24 1961-01-24 Process for the preparation of new aminopyrazoles

Publications (1)

Publication Number Publication Date
FR1731M true FR1731M (en) 1963-03-18

Family

ID=4194763

Family Applications (1)

Application Number Title Priority Date Filing Date
FR885433A Active FR1731M (en) 1961-01-24 1962-01-22 New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.

Country Status (4)

Country Link
CH (1) CH401071A (en)
FR (1) FR1731M (en)
MY (1) MY6600004A (en)
NL (2) NL273881A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789754T2 (en) * 1986-11-20 1994-12-15 Mitsubishi Chem Ind The formation of lipid-peroxide-inhibiting composition and suitable compounds.

Also Published As

Publication number Publication date
CH401071A (en) 1965-10-31
NL273881A (en)
MY6600004A (en) 1966-12-31
NL127998C (en)

Similar Documents

Publication Publication Date Title
FR3639M (en) New protein which can be used in therapy, in particular as an agent for the treatment of solid tumors.
FR1731M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR1856M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR1242M (en) Medicament, which can be used in particular for the treatment of fungal diseases, based on griseofulvin derivatives.
FR1878M (en) New polysaccharide, usable in therapy, in particular for the treatment of solid tumors.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR1783M (en) Stabilized forms of dimethylcarboxy-alkylsulfonium used, in particular, for the treatment of hepatic and vascular disorders.
FR1982M (en) New n-substituted alkanamides-hydrazines, which can be used in particular in the treatment of persistent staphylococcal infections.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR2019M (en) New thioether which can be used in therapy, in particular for the treatment of various solid tumors.
FR28F (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1412M (en) New drug in particular for the treatment of bronchitis, pneumonia, heart collapse and heart failure.
FR3115M (en) New drug which can be used in particular for the treatment of degenerative cardiovascular diseases.
FR2148M (en) Topical composition for the treatment of warts.
FR1611M (en) New drug, for the treatment of inflammatory congestions, in particular of the kidneys.
FR1920M (en) New compound of the hydantoin series which can be used in particular for the treatment of salmonellosis.
FR1305M (en) New drug for external use, in particular for the treatment of dermatological conditions.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1634M (en) New sulfonamide that can be used in therapy, in particular for the treatment of various hepatopathies.
FR1288M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.